Leverage Pharmaceutical Valuation 
PYMNTS
AUGUST 11, 2020
Apple is on the cusp of a stock market first — becoming the first public company in history to capture a $2 trillion valuation. More than a 20 years later, the company is spitting distance from a $2 trillion valuation. So, will Apple make it to a $2 trillion valuation? Apple stock is trading at about $446 as of Tuesday (Aug.
CFO News Room
FEBRUARY 2, 2022
So, you have the headquarters of a big pharmaceutical company, and they — they’re looking to raise some cash, maybe not a pharmaceutical company, but some other business. RITHOLTZ: Is that valuation issue ongoing? RITHOLTZ: I sell the building to you and then do a 50-year lease. It’s a great nonbank source of financing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Barry Ritholtz
DECEMBER 14, 2022
Like, if you think about — when I was growing up, all of the big pharmaceutical companies had these corporate campuses that were highly securitized, deep in suburbs. MCCARTHY: Well, I would — RITHOLTZ: Or is that just leverage and don’t — MCCARTHY: Yeah. MCCARTHY: The Ritz-Carlton, Grand Cayman.
Barry Ritholtz
OCTOBER 8, 2024
And I think what I’m trying to imply is there’s a lot of informational value that’s already held within the valuations where these equities are trading that you can calculate, you know, a sense of the implied market probability of success for an opportunity for a company. There, 00:10:35 [Speaker Changed] There is.
Barry Ritholtz
MARCH 14, 2023
Everybody wants to sell a company when they get a good valuation. Obviously, profits, very important to company valuation — BERNSTEIN: Absolutely. The other thing we do, Barry, is we group valuation as a sentiment indicator. So we do a lot of valuation work. BERNSTEIN: Correct. RITHOLTZ: Right. RITHOLTZ: Oh, really?
Expert insights. Personalized for you.
48 
Let's personalize your content